1 Min Read
Oct 13 (Reuters) - Can Fite Biopharma Ltd :
* Can Fite Biopharma Ltd - Can-Fite submits protocol for phase ii trial of cf102 in treatment of NAFLD/NASH Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.